Nucleic acid extraction for drug developmentHigh-quality RNA and DNA extraction service
GLP, GCLP, and ISO-compliant RNA and DNA extraction supporting advanced therapy bioanalysis and biomarker analysis.
Trusted By
Quality assurance & compliance
Custom-designed regulated assays for absolute quantification for gene therapy, RNA therapeutics, RNA vaccine biodistribution, and relative quantification for biomarker gene expression profiling.
When Should You Choose Our RNA & DNA Extraction Service?
| Choose RNA extraction when… | You need RNA suitable for gene-expression analysis, RT-qPCR, dPCR, RNA sequencing or targeted short-RNA assays; recovery and integrity must match the intended measurement. |
|---|---|
| Choose DNA extraction when… | You need genomic, vector-derived or cell-free DNA for sequencing, copy-number analysis, biodistribution, shedding or targeted molecular assays. |
| Choose custom extraction development when… | Your sample is inhibitor-rich, fixed, degraded, low-input, chemically modified or encapsulated, or a standard protocol has not achieved the required recovery. |
| Choose integrated extraction + analysis when… | You want sample preparation, QC and downstream qPCR, dPCR or sequencing coordinated under one project plan. |
specialized molecular bioanalysis and regulated workflow
RNA & DNA Extraction at SCD
Nucleic acid extraction is more than a preparatory step: it determines which molecules reach the assay and how confidently they can be measured. An efficient method for one specimen may lose important targets in another. We tailor sample disruption, purification, and quality assessment to the matrix, nucleic acid class, and downstream requirements.
Extraction Services & Technical Specifications
| Nucleic acids | Genomic DNA, vector DNA, total RNA, mRNA and selected short RNA classes; other targets assessed case by case |
|---|---|
| Sample matrices | Blood, plasma/serum and other biofluids, tissue, FFPE, fresh-frozen specimens and relevant therapeutic-study matrices |
| Collection formats | PAXgene, EDTA and other compatible collection tubes; cryotubes, microcentrifuge tubes and 96-well plates |
| Extraction formats | Manual and automated purification; protocol selection based on specimen and intended assay |
| Automation | QIAsymphony platforms and LIMS-integrated workflows |
| Method selection | Column, magnetic-bead or organic extraction where appropriate to the sample and analyte |
| Optimization | Lysis, homogenization, capsid or LNP disruption, recovery, inhibitor removal and elution conditions |
| Quality assessment | Yield, purity, integrity, inhibition and target recovery as relevant; exact tests agreed per project |
| Quality framework | Research Use Only (RUO) and applicable GLP/GCLP-associated workflows, subject to site and study scope |
| Deliverables | Extracted nucleic acids, agreed QC measurements and optional downstream analytical results |
Preserve the Molecules That Matter
RNA Extraction
RNA yield alone cannot determine whether an extract is fit for use. The molecular species of interest, sample handling and degradation profile are equally important. SCD adapts extraction strategies for total RNA, mRNA and selected short RNAs, considering target length, secondary structure, chemical modifications and the possibility of low abundance.
Total RNA and mRNA
For transcriptomics or expression assays, extraction should retain the required transcript population while minimizing contaminants that affect reverse transcription, library preparation or amplification. The workflow is chosen around the sample type and the planned analytical readout.
miRNA, siRNA and other short RNA
Small nucleic acids may be under-recovered by procedures optimized for longer RNA. Specialized capture and purification steps can be required, especially for modified therapeutic oligonucleotides. Suitability is evaluated for the individual target.
LNP-encapsulated and therapeutic RNA
For lipid nanoparticle formulations, release of the analyte must be balanced against degradation and loss. Extraction performance can also change when an oligonucleotide is protein-bound or chemically modified.
From Genomic Material to Viral Vector Targets
DNA Extraction
DNA extraction methods must account for target location and accessibility. High-integrity genomic DNA for sequencing requires a different optimization strategy from low-level vector genomes recovered from tissues or biofluids.
Genomic DNA and cfDNA
We select procedures according to required fragment size, yield, purity and downstream use. Cell-free DNA analysis additionally demands attention to pre-analytical handling and the distinction between circulating DNA and genomic DNA released during sample processing.
AAV and other vector-associated DNA
Gene therapy studies may require measurement of free or encapsidated vector DNA. Capsid disruption, tissue lysis and DNA recovery must be optimized for the defined analyte, particularly in biodistribution and shedding studies.
Complex biological matrices
Fibrous tissues may need stronger mechanical or enzymatic disruption; nuclease-rich tissues require careful handling; and fecal or other inhibitor-rich specimens may need additional purification. For FFPE samples, deparaffinization and reversal of fixation-related crosslinks can improve nucleic acid accessibility, although fragmentation cannot always be avoided.
Automation should match the scale and requirements of the project
Manual and Automated Nucleic Acid Extraction
Not every project requires the same level of automation. Small feasibility studies may benefit from flexible manual workflows, while larger sample cohorts often require standardized processing, consistent liquid handling, and reliable sample traceability. Our multiple QIAsymphony extraction platforms support automated nucleic acid purification across a range of sample formats.
However, automation alone does not guarantee optimal results. We evaluate and optimize extraction workflows to ensure suitable nucleic acid recovery and quality for downstream applications, particularly when scaling up from manual protocols to larger sample cohorts.
Fit-for-Purpose Quality Control for Reliable Downstream Results
Quality Control That Matches the Downstream Assay
A high nucleic acid concentration alone does not guarantee good results. We tailor our quality control measures to the intended application, whether PCR, sequencing, biomarker quantification, or regulated bioanalysis.
- Quantity and purity: assess concentration and potential contaminants using suitable analytical methods.
- Integrity and fragment profile: evaluate RNA degradation or DNA fragment size when relevant to the intended application.
- Extraction recovery: use appropriate spike-ins, process controls or reference materials where feasible.
- Inhibitor assessment: check for matrix-associated interference that may affect reverse transcription or amplification.
- Contamination control: assess genomic DNA carryover in RNA workflows or other background contamination as needed.
- Documentation: apply study-appropriate acceptance criteria, traceability and reporting, including validated procedures where required.
Our Extraction Workflow
assessment
analysis
Step 1
1. Sample and study assessment
We review specimen type, collection and storage history, target analyte, expected abundance, sample numbers and downstream testing requirements.
Step 2
2. Protocol selection and feasibility
Our scientists choose a suitable extraction chemistry and, when needed, test lysis, recovery, inhibitor removal or analyte-release conditions.
Step 3
3. Extraction and process monitoring
Samples are processed using the agreed manual or automated workflow, with controls and documentation proportionate to the study.
Step 4
4. Quality assessment
Extracted material is evaluated against relevant yield, purity, integrity, recovery or functional performance criteria.
Step 5
5. Handover or downstream analysis
We deliver extracted material with agreed QC documentation or proceed to qPCR, dPCR, RNA sequencing, DNA sequencing or other contracted services.
Applications
Applications in Drug Development and Molecular Research
- Cell and gene therapy: recover vector genomes and transgene-associated RNA for biodistribution, shedding and expression studies.
- RNA therapeutics: optimize recovery of siRNA, mRNA and selected modified oligonucleotides.
- Biomarker analysis: prepare nucleic acids from tissue and biofluid specimens for targeted verification or longitudinal studies.
- Transcriptomics: obtain RNA suitable for bulk RNA-seq, gene-expression studies and other RNA-based assays.
- Genomics: prepare DNA for sequencing, genotyping, copy-number assessment and selected cell-free DNA applications.
- Clinical research: support defined sample-processing workflows and downstream bioanalysis within the applicable quality framework.
YOUR CRO FROM DISCOVERY TO VALIDATION
Why Choose SCD for RNA & DNA Extraction?
Extraction designed around the biological question
Rather than treating every sample with one generic kit, we select extraction chemistry, sample handling and QC with the molecules you need to measure.
One partner from discovery to validation
We connect discovery-focused single-cell, spatial and sequencing expertise in our labs in Utrecht with specialized molecular assay development and bioanalysis in our labs in Gothenburg. This reduces handovers between sample preparation and downstream interpretation.
Experience with difficult samples and advanced therapies
Our workflows account for fixed and inhibitor-rich matrices, low-abundance analytes, encapsidated vector genomes and chemically modified nucleic acids.
Scalable and documented laboratory workflows
Manual and QIAsymphony-based extraction options can support projects with different sample volumes and levels of standardization. Applicable GLP/GCLP requirements are established during project scoping.
EXPRTISE & EXPERIENCE
Our Scientific Track Record
SCD brings more than a decade of single-cell and sequencing experience together with the molecular bioanalysis legacy of TATAA Biocenter, now TATAA, an SCD company founded in 2001. The combined teams have supported more than 1,000 projects across a wide range of sample types and biological questions.
25+
Years of molecular biology expertise
Building on TATAA’s experience since 2001
1,000+
Research projects supported
Across SCD's broader scientific service portfolio
GLP
Accredited laboratory capabilities
Specialized molecular bioanalysis in Gothenburg, Sweden
Wondering if this service can
help answer your biological question?
Request a quote today and find out how our expertise can support your research.
What our clients say
"The service of Single Cell Discoveries guarantees a smooth process between customer and company. In case of problems or questions, the scientists reacted competently and immediately, so that answers could be found quickly and flexibly."
"Fantastic job made by a really professional and friendly team. I strongly recommend Single Cell Discoveries for sequencing services."
Recent publications using RNA & DNA extraction
bioRxiv
A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader Molecules
bioRxiv
SP140 limits type I interferon-driven pathology, preserving T cell motility and promoting resistance in tuberculosis
Nature Communications
Targeted CRISPR-Cas9 screening identifies core transcription factors controlling murine haemato-endothelial fate commitment
npj Precision Oncology
A single-cell atlas reveals the tumorigenesis and microenvironment status of primary tracheobronchial tumors
Nature Cardiovascular Research
Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term fish heart regeneration
Research Square
GPR124/WNT signaling regulates hyaloid blood vessel regression and endothelial-mesenchymal transition
Case studies
Pioneering 10x Flex on OCT-Embedded Patient Brain Tissue
10x Genomics opened the gates for single-cell sequencing on non-fresh, non-thawed tissue with their Chromium Single Cell Gene Expression Flex (10x Flex) kit. Now, we have been successful in performing…
Immune Profiling of atherosclerosis reveals new therapeutic potential
A team of scientists uses 10x Genomics Single Cell Immune Profiling to characterize T cells in the atherosclerotic plaque. Their results redefine atherosclerosis as an autoimmune disease.
Mechanism of disease: a new hypothesis for atherosclerosis
To elucidate atherosclerosis’ mechanism of disease, Sheffield University researchers analyzed the transcriptomes of single endothelial cells.
Recent blogs related to RNA & DNA extraction
RNA extraction from PAXgene tubes
Controlling and optimizing steps in extracting RNA from PAXgene tubes significantly improves yield and quality and can lead to more accurate preclinical and clinical conclusions. Optimized workflows for PAXgene tubes…
Frequently Asked Questions
Both isolate nucleic acids from biological material, but RNA is generally more susceptible to degradation and often requires additional RNase control. DNA workflows may prioritize high molecular weight or particular target classes such as genomic, vector or cell-free DNA.
We work with tissues, blood-derived samples, biofluids, fresh-frozen and FFPE specimens, and selected specialized matrices. Exact compatibility depends on sample condition, volume, collection method and target analyte.
Yes, suitable methods can be developed or selected for FFPE specimens. Fixation can cause fragmentation and crosslinks, so quality and downstream suitability depend on tissue history and assay requirements.
We support compatible PAXgene and EDTA collection formats. Please contact us for the specifications.
Extraction can be scoped as a standalone preparative service or combined with downstream molecular testing, depending on project requirements.
We assess extracted RNA and DNA quality using a combination of concentration, purity and integrity measurements. Depending on the downstream application, we also evaluate fragment size, potential contaminants and the presence of inhibitors that could affect PCR or sequencing performance. Our quality control criteria are tailored to each project to ensure the extracted nucleic acids are suitable for their intended use.
The extraction depends on target abundance, input amount, matrix and recovery efficiency. We recommend feasibility testing when expected copy numbers are very low.
Yes, extraction strategies can include capsid disruption and subsequent purification. The workflow must be optimized and assessed for the vector and sample matrix.
Specialized workflows can be evaluated to release RNA from LNP formulations while minimizing degradation and loss. Recovery depends on the formulation and RNA chemistry.
These analytes may require dedicated protocols because chemical modifications, size and protein binding can change extraction behavior. Feasibility should be confirmed for the exact molecule.
Column-based extraction uses a solid membrane to bind nucleic acids; magnetic-bead methods capture targets on particles that can be separated magnetically and often support automation. The best option depends on matrix, analyte, yield and throughput needs.
Yes. We use multiple QIAsymphony platforms and LIMS-integrated workflows. Current instrument availability and project throughput should be confirmed when requesting a quote.
Our laboratory in Gothenburg has GLP-accredited molecular biology capabilities and supports GCLP workflows. Whether extraction for a particular project falls within the applicable regulated scope must be verified during scoping.
Input requirements depend on matrix, expected target concentration, extraction chemistry and downstream assays. We can assess feasibility from your sample inventory and study objectives.
Yes. SCD offers complementary qPCR, dPCR, RNA sequencing and DNA sequencing services, allowing sample preparation and analysis to be coordinated where appropriate.
Please provide sample type and count, collection tubes, storage conditions, target DNA/RNA species, any modifications or encapsulation, downstream application, required QC, timeline and regulatory expectations.
Request a quote
Discuss Your Samples with Our Scientists
Whether your samples are straightforward or technically demanding, we can help establish a preparation workflow suited to your target and intended analysis. Tell us what material you have, what you need to measure and how the results will be used.